Starna Therapeutics
Starna Therapeutics
Explore linked clinical trials.6 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Early Clinical Study on the Safety, Tolerability, Pharmacokinetics, and Efficacy of STR-P005 | autoimmune disease, immune system disorder | Not yet recruiting | Not applicable | 2026-06-17 | NCT07655453 | |
| Early Clinical Study of the Safety, Tolerability, Pharmacokinetics, and Effectiveness of STR-P005 | autoimmune disease, immune system disorder | Not yet recruiting | Not applicable | 2026-05-26 | NCT07605637 | |
| Exploratory Clinical Study on the Safety of STR-P004 | autoimmune disease, immune system disorder | Recruiting | Not applicable | 2026-03-09 | NCT07143617 | |
| To Evaluate the Safety and Tolerability of STR-P004 for the Treatment of Immune-mediated Kidney Diseases | autoimmune disease, immune system disorder | Not yet recruiting | Not applicable | 2026-01-23 | NCT07363954 | |
| To Evaluate the Safety, Tolerability, and Preliminary Antitumor Activity of STR-P004 | Acute Lymphobkastic Leukemia | Not yet recruiting | Not applicable | 2025-11-24 | NCT07245251 | |
| A Study to Evaluate the Safety and Clinical Efficacy of STR-P004 | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, non-Hodgkin lymphoma | Not yet recruiting | Early phase 1 | 2025-06-04 | NCT07003178 |